These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

274 related articles for article (PubMed ID: 19801534)

  • 21. Association of Insulin Resistance With Cerebral Glucose Uptake in Late Middle-Aged Adults at Risk for Alzheimer Disease.
    Willette AA; Bendlin BB; Starks EJ; Birdsill AC; Johnson SC; Christian BT; Okonkwo OC; La Rue A; Hermann BP; Koscik RL; Jonaitis EM; Sager MA; Asthana S
    JAMA Neurol; 2015 Sep; 72(9):1013-20. PubMed ID: 26214150
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Serum levels of vitamin E forms and risk of cognitive impairment in a Finnish cohort of older adults.
    Mangialasche F; Solomon A; Kåreholt I; Hooshmand B; Cecchetti R; Fratiglioni L; Soininen H; Laatikainen T; Mecocci P; Kivipelto M
    Exp Gerontol; 2013 Dec; 48(12):1428-35. PubMed ID: 24113154
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Differential impact of cerebral white matter changes, diabetes, hypertension and stroke on cognitive performance among non-disabled elderly. The LADIS study.
    Verdelho A; Madureira S; Ferro JM; Basile AM; Chabriat H; Erkinjuntti T; Fazekas F; Hennerici M; O'Brien J; Pantoni L; Salvadori E; Scheltens P; Visser MC; Wahlund LO; Waldemar G; Wallin A; Inzitari D;
    J Neurol Neurosurg Psychiatry; 2007 Dec; 78(12):1325-30. PubMed ID: 17470472
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Bodyweight change and cognitive performance in the older population.
    Kronschnabl JM; Kneip T; Weiss LM; Bergmann M
    PLoS One; 2021; 16(4):e0249651. PubMed ID: 33882068
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Shared Neuropathological Characteristics of Obesity, Type 2 Diabetes and Alzheimer's Disease: Impacts on Cognitive Decline.
    Walker JM; Harrison FE
    Nutrients; 2015 Sep; 7(9):7332-57. PubMed ID: 26340637
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Cerebral hypoperfusion and glucose hypometabolism: Key pathophysiological modulators promote neurodegeneration, cognitive impairment, and Alzheimer's disease.
    Daulatzai MA
    J Neurosci Res; 2017 Apr; 95(4):943-972. PubMed ID: 27350397
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Peripheral and Central Effects of Memantine in a Mixed Preclinical Mice Model of Obesity and Familial Alzheimer's Disease.
    Ettcheto M; Sánchez-López E; Gómez-Mínguez Y; Cabrera H; Busquets O; Beas-Zarate C; García ML; Carro E; Casadesus G; Auladell C; Vázquez Carrera M; Folch J; Camins A
    Mol Neurobiol; 2018 Sep; 55(9):7327-7339. PubMed ID: 29404958
    [TBL] [Abstract][Full Text] [Related]  

  • 28. APOE-4 genotype and neurophysiological vulnerability to Alzheimer's and cognitive aging.
    Bookheimer S; Burggren A
    Annu Rev Clin Psychol; 2009; 5():343-62. PubMed ID: 19327032
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Association between memory complaints and incident Alzheimer's disease in elderly people with normal baseline cognition.
    Geerlings MI; Jonker C; Bouter LM; Adèr HJ; Schmand B
    Am J Psychiatry; 1999 Apr; 156(4):531-7. PubMed ID: 10200730
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Effects of blood pressure changes on Alzheimer's disease.
    Feldstein CA
    Neuroepidemiology; 2010; 35(3):202-12. PubMed ID: 20664211
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Vascular risk factors and progression in Alzheimer's disease.
    Sakurai H; Hanyu H; Sato T; Kanetaka H; Shimizu S; Hirao K; Kikukawa M; Iwamoto T
    Geriatr Gerontol Int; 2011 Apr; 11(2):211-4. PubMed ID: 21143566
    [TBL] [Abstract][Full Text] [Related]  

  • 32. White matter hyperintensities and imaging patterns of brain ageing in the general population.
    Habes M; Erus G; Toledo JB; Zhang T; Bryan N; Launer LJ; Rosseel Y; Janowitz D; Doshi J; Van der Auwera S; von Sarnowski B; Hegenscheid K; Hosten N; Homuth G; Völzke H; Schminke U; Hoffmann W; Grabe HJ; Davatzikos C
    Brain; 2016 Apr; 139(Pt 4):1164-79. PubMed ID: 26912649
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Relationships of Dietary Patterns, Foods, and Micro- and Macronutrients with Alzheimer's Disease and Late-Life Cognitive Disorders: A Systematic Review.
    Solfrizzi V; Custodero C; Lozupone M; Imbimbo BP; Valiani V; Agosti P; Schilardi A; D'Introno A; La Montagna M; Calvani M; Guerra V; Sardone R; Abbrescia DI; Bellomo A; Greco A; Daniele A; Seripa D; Logroscino G; Sabbá C; Panza F
    J Alzheimers Dis; 2017; 59(3):815-849. PubMed ID: 28697569
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Inflammation and gut-brain axis link obesity to cognitive dysfunction: plausible pharmacological interventions.
    Solas M; Milagro FI; Ramírez MJ; Martínez JA
    Curr Opin Pharmacol; 2017 Dec; 37():87-92. PubMed ID: 29107872
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Insulin resistance in the brain: an old-age or new-age problem?
    Williamson R; McNeilly A; Sutherland C
    Biochem Pharmacol; 2012 Sep; 84(6):737-45. PubMed ID: 22634336
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Incident Impaired Cognitive Function in Sarcopenic Obesity: Data From the National Health and Aging Trends Survey.
    Batsis JA; Haudenschild C; Roth RM; Gooding TL; Roderka MN; Masterson T; Brand J; Lohman MC; Mackenzie TA
    J Am Med Dir Assoc; 2021 Apr; 22(4):865-872.e5. PubMed ID: 34248422
    [TBL] [Abstract][Full Text] [Related]  

  • 37. From mild cognitive impairment to Alzheimer's disease - influence of homocysteine, vitamin B12 and folate on cognition over time: results from one-year follow-up.
    Siuda J; Gorzkowska A; Patalong-Ogiewa M; Krzystanek E; Czech E; Wiechuła B; Garczorz W; Danch A; Jasińska-Myga B; Opala G
    Neurol Neurochir Pol; 2009; 43(4):321-9. PubMed ID: 19742390
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Penn study shows vascular link in Alzheimer's disease with cognition. Presence of vascular disease reported across different neurodegenerative diseases.
    Am J Alzheimers Dis Other Demen; 2013 Sep; 28(6):646-7. PubMed ID: 24137744
    [No Abstract]   [Full Text] [Related]  

  • 39. Vascular cognitive impairment.
    Gilbert DT
    West Indian Med J; 2007 Dec; 56(6):479-80. PubMed ID: 18646488
    [No Abstract]   [Full Text] [Related]  

  • 40. Relationship between sarcopenic obesity and cognitive function in patients with mild to moderate Alzheimer's disease.
    Weng XF; Liu SW; Li M; Zhang Y; Zhang YC; Liu CF; Zhu JT; Hu H
    Psychogeriatrics; 2023 Nov; 23(6):944-953. PubMed ID: 37652079
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 14.